Here we provide you with HIV & TB drug resistance information in the form of reports, clinical cases, tweets and publications.
In this new section of the bioafrica.net website, physicians, researchers and public health officials can learn about our drug resistance work and its application to the management of patients failing ARVs and anti-TB therapies.
By Justen Manasa - 2013-08-21
SATuRN 2013 report
By Dean Solomon and Tulio de Oliveira - 2013-08-01
SATuRN 2013 report
Major data analysis determines the trends of HIV-1 drug resistance mutations in South Africa.
By Tulio de Oliveira - 2013-07-01
SATuRN report 2013
By Tulio de Oliveira, Justen Manasa, Richard Lessells - 2013-03-16
SATuRN 2013 report
Bioafrica.net & SATuRN webpages received 186,746 visits in the past 12 months!
By Tulio de Oliveira - 2013-02-26
SATuRN 2013 report
Clinical Case Study: The Diagnosis and Management of First-line Antiretroviral Treatment Failure
By Theresa Rossouw, Tulio de Oliveira & Richard Lessells - 2013-01-16
SATuRN 2012 report
By Dominique Goedhals & Cloete van Vuuren - 2012-07-10
SATuRN 2012 report
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study. eClinicalMedicine (2025), I.F.:
Investing in Africa's scientific future. Science (2024), I.F.:
SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations. Virus Evolution (2024), I.F.:
Save lives in the next pandemic: ensure vaccine equity now. Nature (2024), I.F.:
Addressing pandemic-wide systematic errors in the SARS-CoV-2 phylogeny. bioRxiv [Preprint] (2024), I.F.:
An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution. Nature Medicine (2024), I.F.:
Managing and assembling population-scale data streams, tools and workflows to plan for future pandemics within the INFORM-Africa Consortium. S Afr J Sci. (2024), I.F.:
Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation. Nature Communications (2024), I.F.:
A new lineage nomenclature to aid genomic surveillance of dengue virus. medRxiv [Preprint] (2024), I.F.:
Disentangling seasonal introduction and establishment risk of dengue in Africa. medRxiv [Preprint] (2024), I.F.:
KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).
Location: K-RITH Tower Building
Nelson R Mandela School of Medicine, UKZN
719 Umbilo Road, Durban, South Africa.
Director: Prof. Tulio de Oliveira